Julie Rubinstein, President and COO at Adaptive Biotechnologies Corp (ADPT), sold 92,823 shares at $15.49 ($1.5M) on 2026-03-03, disclosed to the SEC on 2026-03-05.
Seasonal sale ($1.5M) by President and COO — this insider has traded ADPT in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.49 | 24,423 | $378K | 25.3% |
| 2 | $16.33 | 6,518 | $106K | 7.1% |
| 3 | $16.60 | 30,941 | $514K | 34.4% |
| 4 | $16.00 | 30,941 | $495K | 33.1% |
| Total | $16.09 avg | 92,823 | $1.5M | 100% |
| Filing → |
| ADPT | SELL | 2026-10-05 | $1.0M | — | Filing → |
| ADPT | SELL | 2026-04-29 | $271K | — | Filing → |
| ADPT | SELL | 2026-04-24 | $798K | — | Filing → |